HomeBBN • SWX
add
Bellevue Group AG
Previous close
CHF 18.80
Day range
CHF 18.85 - CHF 19.30
Year range
CHF 18.20 - CHF 32.50
Market cap
256.44M CHF
Avg Volume
13.62K
P/E ratio
16.56
Dividend yield
6.04%
Primary exchange
SWX
Market news
ACN
0.32%
1.32%
Financials
Income Statement
Revenue
Net income
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 20.20M | -17.91% |
Operating expense | 15.57M | -11.70% |
Net income | 3.61M | -34.55% |
Net profit margin | 17.86 | -20.27% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 24.02% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 38.83M | -39.96% |
Total assets | 155.54M | -16.02% |
Total liabilities | 33.08M | -35.56% |
Total equity | 122.47M | — |
Shares outstanding | 13.16M | — |
Price to book | 2.02 | — |
Return on assets | 9.28% | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 3.61M | -34.55% |
Cash from operations | 14.23M | -15.08% |
Cash from investing | -34.00K | 62.01% |
Cash from financing | -2.07M | 18.93% |
Net change in cash | 11.82M | -14.53% |
Free cash flow | — | — |
About
Bellevue Group AG, headquartered in Küsnacht, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
CEO
Founded
1993
Website
Employees
94